- Home
- RGEN vs PAC Comparison
RGEN vs PAC Comparison
Compare RGEN & PAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- PAC
- Stock Information
- Founded
- RGEN 1981
- PAC 1998
- Country
- RGEN United States
- PAC Mexico
- Employees
- RGEN N/A
- PAC N/A
- Industry
- RGEN Medical/Dental Instruments
- PAC Aerospace
- Sector
- RGEN Health Care
- PAC Consumer Discretionary
- Exchange
- RGEN Nasdaq
- PAC Nasdaq
- Market Cap
- RGEN 7.1B
- PAC 9.7B
- IPO Year
- RGEN N/A
- PAC 2006
- Fundamental
- Price
- RGEN $128.50
- PAC $188.31
- Analyst Decision
- RGEN Buy
- PAC Buy
- Analyst Count
- RGEN 12
- PAC 6
- Target Price
- RGEN $177.78
- PAC $207.50
- AVG Volume (30 Days)
- RGEN 756.1K
- PAC 79.3K
- Earning Date
- RGEN 04-30-2025
- PAC 04-21-2025
- Dividend Yield
- RGEN N/A
- PAC 3.85%
- EPS Growth
- RGEN N/A
- PAC N/A
- EPS
- RGEN N/A
- PAC 0.84
- Revenue
- RGEN $634,439,000.00
- PAC $1,285,277,140.00
- Revenue This Year
- RGEN $12.24
- PAC $54.55
- Revenue Next Year
- RGEN $15.24
- PAC $8.09
- P/E Ratio
- RGEN N/A
- PAC $21.96
- Revenue Growth
- RGEN 0.33
- PAC 5.30
- 52 Week Low
- RGEN $113.50
- PAC $146.62
- 52 Week High
- RGEN $182.52
- PAC $205.35
- Technical
- Relative Strength Index (RSI)
- RGEN 34.73
- PAC 48.76
- Support Level
- RGEN $135.71
- PAC $182.63
- Resistance Level
- RGEN $147.00
- PAC $196.68
- Average True Range (ATR)
- RGEN 6.09
- PAC 5.38
- MACD
- RGEN -1.57
- PAC -0.18
- Stochastic Oscillator
- RGEN 12.43
- PAC 34.80
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.